Soft robot intubation device, designed specifically for non-expert users, could save lives

Updated on: October 01,2025 0

Soft robot intubation device, designed specifically for non-expert users, could save lives

Updated on:October 01,2025 0

Missing Y gene linked to male infertility

Updated on: October 01,2025 0

Missing Y gene linked to male infertility

Updated on:October 01,2025 0

Video-assisted thoracoscopy surgery reduces mortality by 21% compared to lobectomy, meta-analysis suggests

Updated on: October 03,2025 0

Video-assisted thoracoscopy surgery reduces mortality by 21% compared to lobectomy, meta-analysis suggests

Updated on:October 03,2025 0

Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

Updated on: October 03,2025 0

Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

Updated on:October 03,2025 0

How brain fluid dynamics drive cancer spread—and ways to fight back

Updated on: October 03,2025 0

How brain fluid dynamics drive cancer spread—and ways to fight back

Updated on:October 03,2025 0

How does chemotherapy disrupt circadian rhythms?

Updated on: October 04,2025 0

How does chemotherapy disrupt circadian rhythms?

Updated on:October 04,2025 0

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Updated on: October 05,2025 0

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Updated on:October 05,2025 0

Lung cancer rewires immune cells in bone marrow to weaken body's defenses

Updated on: October 02,2025 0

Lung cancer rewires immune cells in bone marrow to weaken body's defenses

Updated on:October 02,2025 0

How small cell lung cancer hijacks neuronal synapses

Updated on: October 07,2025 0

How small cell lung cancer hijacks neuronal synapses

Updated on:October 07,2025 0

Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC

Updated on: October 03,2025 0

Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC

Updated on:October 03,2025 0